|
TM
|
Consumer Cyclical |
Freedom Broker |
Downgrade
|
Buy
→
Hold
|
—
|
$243.2B
|
$202.94
|
-0.2%
|
-0.5%
|
+1.0%
|
+1.0%
|
+0.6%
|
-1.9%
|
|
WRB
|
Financial Services |
UBS |
Downgrade
|
Buy
→
Neutral
|
—
|
$27.3B
|
$74.58
|
-0.5%
|
+0.5%
|
+1.2%
|
+0.7%
|
+0.4%
|
+0.4%
|
|
BSAC
|
Financial Services |
Citigroup |
Downgrade
|
Buy
→
Neutral
|
—
|
$14.7B
|
$29.18
|
+0.8%
|
+1.8%
|
+0.7%
|
+1.1%
|
+0.7%
|
-2.9%
|
|
KMX
|
Consumer Cyclical |
Needham |
Downgrade
|
Buy
→
Hold
|
—
|
$5.4B
|
$30.88
|
-0.4%
|
+4.8%
|
+2.8%
|
+2.7%
|
+0.8%
|
+1.1%
|
|
KMX
|
Consumer Cyclical |
RBC Capital |
Downgrade
|
Outperform
→
Sector Perform
|
—
|
$5.4B
|
$30.88
|
-0.4%
|
+4.8%
|
+2.8%
|
+2.7%
|
+0.8%
|
+1.1%
|
|
COLD
|
Real Estate |
Evercore ISI |
Downgrade
|
Outperform
→
In Line
|
—
|
$4.0B
|
$11.86
|
-1.9%
|
-0.9%
|
-3.9%
|
+0.5%
|
-2.6%
|
-3.0%
|
|
COLD
|
Real Estate |
RBC Capital |
Downgrade
|
Outperform
→
Sector Perform
|
—
|
$4.0B
|
$11.86
|
-1.9%
|
-0.9%
|
-3.9%
|
+0.5%
|
-2.6%
|
-3.0%
|
|
PENN
|
Consumer Cyclical |
Needham |
Downgrade
|
Buy
→
Hold
|
—
|
$2.3B
|
$14.65
|
+0.3%
|
-0.8%
|
+7.3%
|
-0.7%
|
-1.4%
|
-3.1%
|
|
BL
|
Technology |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$2.2B
|
$56.82
|
-8.1%
|
-5.7%
|
+1.7%
|
+1.5%
|
+1.5%
|
-1.2%
|
|
XRAY
|
Healthcare |
William Blair |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$1.9B
|
$11.02
|
-1.8%
|
+1.5%
|
-1.6%
|
-0.2%
|
-1.3%
|
+1.0%
|
|
ABCL
|
Healthcare |
Leerink Partners |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$1.4B
|
$4.53
|
-16.1%
|
-13.7%
|
+3.1%
|
-0.5%
|
-1.0%
|
-8.8%
|
|
NTLA
|
Healthcare |
JP Morgan |
Downgrade
|
Neutral
→
Underweight
|
—
|
$1.3B
|
$12.32
|
-25.7%
|
-22.7%
|
+2.2%
|
+4.6%
|
-6.8%
|
-8.6%
|
|
SG
|
Consumer Cyclical |
William Blair |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$1.0B
|
$6.25
|
-16.0%
|
-7.5%
|
-6.1%
|
-3.7%
|
+2.7%
|
+10.6%
|
|
CCOI
|
Communication Services |
Wells Fargo |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$852M
|
$24.95
|
-3.1%
|
-5.9%
|
-5.8%
|
-6.8%
|
-10.3%
|
-9.8%
|
|
CCOI
|
Communication Services |
UBS |
Downgrade
|
Buy
→
Neutral
|
—
|
$852M
|
$24.95
|
-3.1%
|
-5.9%
|
-5.8%
|
-6.8%
|
-10.3%
|
-9.8%
|
|
GDEN
|
Consumer Cyclical |
Citizens |
Downgrade
|
Market Outperform
→
Market Perform
|
—
|
$750M
|
$28.52
|
-0.9%
|
+2.5%
|
+0.2%
|
+1.9%
|
-0.4%
|
-0.5%
|
|
TMCI
|
Healthcare |
JP Morgan |
Downgrade
|
Neutral
→
Underweight
|
—
|
$172M
|
$6.23
|
-37.4%
|
-28.3%
|
-20.4%
|
-5.6%
|
-0.9%
|
-5.7%
|
|
TMCI
|
Healthcare |
BTIG |
Downgrade
|
Buy
→
Neutral
|
—
|
$172M
|
$6.23
|
-37.4%
|
-28.3%
|
-20.4%
|
-5.6%
|
-0.9%
|
-5.7%
|
|
TEAD
|
Technology |
Citizens |
Downgrade
|
Market Outperform
→
Market Perform
|
—
|
$116M
|
$0.79
|
+0.0%
|
-8.6%
|
+34.3%
|
-7.8%
|
-9.6%
|
+3.1%
|
|
SGMO
|
Healthcare |
Barclays |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$66M
|
$0.46
|
+0.3%
|
+2.5%
|
+9.0%
|
-2.3%
|
-6.4%
|
-4.4%
|